CP-2090

N/A

Report date: 2025/08/01 16:03:03

NME

Base Information

Drug NameCP-2090

Drug Alias NameCP-2090

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLysophosphatidic acid receptors antagonists

TargetsLysophosphatidic acid receptors

Therapy Area/IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUbe Industries Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

ATC CodeN/A